NURC 1143 (NURC1143)

Medication administration-Eye ◆ Mydriatics (apraclonidine/Iopidine) - Dilate the pupil • Reduces IOP 23-39% by stimulating alpha2 & beta2 receptors • Prevents ocular vasoconstriction-reduces ocular bp as well as aqueous humor formation • Used to inhibit perioperative IOP increases rather than treat glaucoma • Burning, eye pain, lacrimation, rare systemic effects: HTN, tachycardia, extrasystoles ◆ Miotics (acetylcholine, pilocarpine)- Constrict the pupil ◆ Cycloplegics (atrop...

1 Medication administration-Eye  Mydriatics (apraclonidine/Iopidine) - Dilate the pupil  Reduces IOP 23-39% by stimulating alpha2 & beta2 receptors  Prevents ocular vasoconstriction-reduces ocular bp as well as aqueous humor formation  Used to inhibit perioperative IOP increases rather than treat glaucoma  Burning, eye pain, lacrimation, rare systemic effects: HTN, tachycardia, extrasystoles  Miotics (acetylcholine, pilocarpine)- Constrict the pupil  Cycloplegics (atropine, ...

1 Medication administration-Eye  Mydriatics (apraclonidine/Iopidine) - Dilate the pupil  Reduces IOP 23-39% by stimulating alpha2 & beta2 receptors  Prevents ocular vasoconstriction-reduces ocular bp as well as aqueous humor formation  Used to inhibit perioperative IOP increases rather than treat glaucoma  Burning, eye pain, lacrimation, rare systemic effects: HTN, tachycardia, extrasystoles  Miotics (acetylcholine, pilocarpine)- Constrict the pupil  Cycloplegics (atropine, ...